| VWF protects FVIII from endocytosis by dendritic cells and subsequent presentation to immune effectors S Dasgupta, Y Repessé, J Bayry, AM Navarrete, B Wootla, S Delignat, ... Blood 109 (2), 610-612, 2007 | 247 | 2007 |
| Potent Thrombolytic Effect of N-Acetylcysteine on Arterial Thrombi S Martinez de Lizarrondo, C Gakuba, BA Herbig, Y Repessé, C Ali, ... Circulation 136 (7), 646-660, 2017 | 146 | 2017 |
| The interaction between factor H and VWF increases factor H cofactor activity and regulates VWF prothrombotic status J Rayes, LT Roumenina, JD Dimitrov, Y Repessé, M Ing, O Christophe, ... Blood, The Journal of the American Society of Hematology 123 (1), 121-125, 2014 | 85 | 2014 |
| GpIbα-VWF blockade restores vessel patency by dissolving platelet aggregates formed under very high shear rate in mice A Le Behot, M Gauberti, S Martinez De Lizarrondo, A Montagne, ... Blood, The Journal of the American Society of Hematology 123 (21), 3354-3363, 2014 | 76 | 2014 |
| Factor VIII (FVIII) gene mutations in 120 patients with hemophilia A: detection of 26 novel mutations and correlation with FVIII inhibitor development Y Repesse, M Slaoui, D Ferrandiz, P Gautier, C Costa, JM Costa, ... Journal of Thrombosis and Haemostasis 5 (7), 1469-1476, 2007 | 74 | 2007 |
| The burden of inhibitors in haemophilia patients CE Walsh, V Jiménez-Yuste, G Auerswald, S Grancha Thrombosis and Haemostasis 116 (S 01), S10-S17, 2016 | 71 | 2016 |
| Immunoprotective effect of von Willebrand factor towards therapeutic factor VIII in experimental haemophilia A S Delignat, Y Repessé, AM Navarrete, Y Meslier, N Gupta, OD Christophe, ... Haemophilia 18 (2), 248-254, 2012 | 68 | 2012 |
| Development of inhibitory antibodies to therapeutic factor VIII in severe hemophilia A is associated with microsatellite polymorphisms in the HMOX1 promoter Y Repessé, I Peyron, JD Dimitrov, S Dasgupta, EF Moshai, C Costa, ... haematologica 98 (10), 1650, 2013 | 44 | 2013 |
| Factor VIII inhibitors: role of von Willebrand factor on the uptake of factor VIII by dendritic cells SV Kaveri, S Dasgupta, S Andre, AM Navarrete, Y Repesse, B Wootla, ... Haemophilia 13, 61-64, 2007 | 43 | 2007 |
| A cellular viewpoint of anti-FVIII immune response in hemophilia A S André, Y Meslier, JD Dimitrov, Y Repessé, SV Kaveri, ... Clinical reviews in allergy & immunology 37, 105-113, 2009 | 42 | 2009 |
| Induction of heme oxygenase-1 in factor VIII–deficient mice reduces the immune response to therapeutic factor VIII JD Dimitrov, S Dasgupta, AM Navarrete, S Delignat, Y Repesse, Y Meslier, ... Blood, The Journal of the American Society of Hematology 115 (13), 2682-2685, 2010 | 40 | 2010 |
| Factor VIII bypasses CD91/LRP for endocytosis by dendritic cells leading to T-cell activation S Dasgupta, AM Navarrete, S Andre, B Wootla, S Delignat, Y Repesse, ... Haematologica 93 (1), 83-89, 2008 | 40 | 2008 |
| Proteolytic antibodies activate factor IX in patients with acquired hemophilia B Wootla, OD Christophe, A Mahendra, JD Dimitrov, Y Repessé, V Ollivier, ... Blood, The Journal of the American Society of Hematology 117 (7), 2257-2264, 2011 | 38 | 2011 |
| Heme binds to factor VIII and inhibits its interaction with activated factor IX Y Repessé, JD Dimitrov, I Peyron, EF Moshai, L Kiger, S Dasgupta, ... Journal of Thrombosis and Haemostasis 10 (6), 1062-1071, 2012 | 30 | 2012 |
| Thermodynamic analysis of the interaction of factor VIII with von Willebrand factor JD Dimitrov, OD Christophe, J Kang, Y Repesse, S Delignat, SV Kaveri, ... Biochemistry 51 (20), 4108-4116, 2012 | 28 | 2012 |
| In silico calculated affinity of FVIII‐derived peptides for HLA class II alleles predicts inhibitor development in haemophilia A patients with missense mutations in the … AD Pashov, T Calvez, L Gilardin, B Maillère, Y Repesse, J Oldenburg, ... Haemophilia 20 (2), 176-184, 2014 | 26 | 2014 |
| Mannose-sensitive receptors mediate the uptake of factor VIII therapeutics by human dendritic cells Y Repessé, S Dasgupta, AM Navarrete, S Delignat, SV Kaveri, ... Journal of Allergy and Clinical Immunology 129 (4), 1172-1173, 2012 | 25 | 2012 |
| Genetic risk factors and inhibitor development in hemophilia: What is known and searching for the unknown M Margaglione, M Intrieri Seminars in thrombosis and hemostasis 44 (06), 509-516, 2018 | 23 | 2018 |
| The role of VWF in the immunogenicity of FVIII S Lacroix-Desmazes, Y Repessé, SV Kaveri, S Dasgupta Thrombosis Research 122, S3-S6, 2008 | 22 | 2008 |
| Influence of factor VIII level and its inhibitor titer on the therapeutic response to corticosteroids alone in the management of acquired hemophilia: a retrospective single … M Vautier, H De Boysson, C Creveuil, Y Repesse, A Borel-Derlon, ... Medicine 95 (48), e5232, 2016 | 21 | 2016 |
Edouard CornetCHU Caen - Université de Caen在 chu-caen.fr 的电子邮件经过验证
Edouard CornetCHU Caen - Université de Caen在 chu-caen.fr 的电子邮件经过验证